Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| UNC5A | Q6ZN44 | Netrin receptor UNC5A (Protein unc-5 homolog 1) (Protein unc-5 homolog A) | 1 | Fusion and delivery mediation | 1 | 0.50 | ||||
| UNC79 | Q9P2D8 | Protein unc-79 homolog | 2 | Fusion and delivery mediation | 1 | 0.50 | ||||
| UT1 | Q13336 | Urea transporter 1 (Solute carrier family 14 member 1) (Urea transporter, erythrocyte) | Blood group antigen proteinsMetabolic proteinsPredicted intracellular proteins | 9 | Clinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| VAMP5 | O95183 | Vesicle-associated membrane protein 5 (VAMP-5) (Myobrevin) | Predicted membrane proteins | 1 | Fusion and delivery mediation | 1 | 0.50 | |||
| VAMP8 | Q9BV40 | Vesicle-associated membrane protein 8 (VAMP-8) (Endobrevin) (EDB) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediationImmune mediation | 1 | 0.50 | |||
| VGFR1 | P17948 | Vascular endothelial growth factor receptor 1 (VEGFR-1) (EC 2.7.10.1) (Fms-like tyrosine kinase 1) (FLT-1) (Tyrosine-protein kinase FRT) (Tyrosine-protein kinase receptor FLT) (FLT) (Vascular permeability factor receptor) | Cancer-related genesDisease related genesEnzymes | 1 | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 1 | 0.50 | |||
| VTCN1 | Q7Z7D3 | V-set domain-containing T-cell activation inhibitor 1 (B7 homolog 4) (B7-H4) (B7h.5) (Immune costimulatory protein B7-H4) (Protein B7S1) (T-cell costimulatory molecule B7x) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Breast cancerSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | ||
| ZDH20 | Q5W0Z9 | Palmitoyltransferase ZDHHC20 (EC 2.3.1.225) (Acyltransferase ZDHHC20) (EC 2.3.1.-) (DHHC domain-containing cysteine-rich protein 20) (DHHC20) (Zinc finger DHHC domain-containing protein 20) | EnzymesMetabolic proteinsPredicted membrane proteins | 4 | Clinical-translation mediation | 1 | 0.50 | |||
| ZDHC2 | Q9UIJ5 | Palmitoyltransferase ZDHHC2 (EC 2.3.1.225) (Acyltransferase ZDHHC2) (EC 2.3.1.-) (Reduced expression associated with metastasis protein) (Ream) (Reduced expression in cancer protein) (Rec) (Zinc finger DHHC domain-containing protein 2) (DHHC-2) (Zinc finger protein 372) | EnzymesMetabolic proteinsPredicted intracellular proteins | 4 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.50 | |||
| CC50B | Q3MIR4 | Cell cycle control protein 50B (P4-ATPase flippase complex beta subunit TMEM30B) (Transmembrane protein 30B) | Predicted membrane proteinsTransporters | 2 | Fusion and delivery mediation | 20 | 0.47 | |||
| CBPD | O75976 | Carboxypeptidase D (EC 3.4.17.22) (Metallocarboxypeptidase D) (gp180) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationMetabolism mediationReceptor-signaling mediation | 16 | 0.47 | |||
| ITM2B | Q9Y287 | Integral membrane protein 2B (Immature BRI2) (imBRI2) (Protein E25B) (Transmembrane protein BRI) (Bri) [Cleaved into: BRI2, membrane form (Mature BRI2) (mBRI2); BRI2 intracellular domain (BRI2 ICD); BRI2C, soluble form; Bri23 peptide (Bri2-23) (ABri23) (C-terminal peptide) (P23 peptide)] | Disease related genesHuman disease related genesPotential drug targets | 1 | Fusion and delivery mediationMetabolism mediation | 16 | 0.47 | |||
| STIM1 | Q13586 | Stromal interaction molecule 1 | Disease related genesHuman disease related genesPlasma proteins | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 15 | 0.47 | |||
| CD82 | P27701 | CD82 antigen (C33 antigen) (IA4) (Inducible membrane protein R2) (Metastasis suppressor Kangai-1) (Suppressor of tumorigenicity 6 protein) (Tetraspanin-27) (Tspan-27) (CD antigen CD82) | Cancer-related genesCD markersPlasma proteins | 4 | Clinical-translation mediationFusion and delivery mediation | 14 | 0.47 | |||
| DRB4 | P13762 | HLA class II histocompatibility antigen, DR beta 4 chain (MHC class II antigen DRB4) | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 14 | 0.47 | ||||
| TSN8 | P19075 | Tetraspanin-8 (Tspan-8) (Transmembrane 4 superfamily member 3) (Tumor-associated antigen CO-029) | Cancer-related genesPredicted membrane proteins | 4 | Immune mediation | 14 | 0.47 | |||
| ADCY6 | O43306 | Adenylate cyclase type 6 (EC 4.6.1.1) (ATP pyrophosphate-lyase 6) (Adenylate cyclase type VI) (Adenylyl cyclase 6) (Ca(2+)-inhibitable adenylyl cyclase) | Disease related genesEnzymesHuman disease related genes | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 12 | 0.47 | |||
| CAD11 | P55287 | Cadherin-11 (OSF-4) (Osteoblast cadherin) (OB-cadherin) | Cancer-related genesDisease related genesHuman disease related genes | 1 | Rheumatoid arthritis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 12 | 0.47 | ||
| CD22 | P20273 | B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22) | CD markersFDA approved drug targetsPlasma proteins | 1 | Acute myeloid leukaemiaB-cell lymphomaDiabetes mellitus | Clinical-translation mediationFusion and delivery mediationImmune mediation | 12 | 0.47 | ||
| NLGN2 | Q8NFZ4 | Neuroligin-2 | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Adhesion and uptake mediationFusion and delivery mediation | 12 | 0.47 | |||
| CAD17 | Q12864 | Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin) (LI-cadherin) | Cancer-related genesPlasma proteinsPredicted intracellular proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 11 | 0.47 | |||
| FGFR3 | P22607 | Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333) | Cancer-related genesCD markersDisease related genes | 1 | Alzheimer diseaseBladder cancerBreast cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 11 | 0.47 | ||
| K319L | Q8IZA0 | Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR) | Predicted intracellular proteinsPredicted membrane proteins | 2 | Other mediation | 10 | 0.38 | |||
| MUC16 | Q8WXI7 | Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125) | Plasma proteinsPredicted membrane proteinsPredicted secreted proteins | 1 | Fallopian tube cancerMalignant mesenchymal neoplasmMature B-cell lymphoma | Clinical-translation mediationFusion and delivery mediationImmune mediation | 10 | 0.38 | ||
| BST2 | Q10589 | Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317) | CD markersPlasma proteinsPredicted membrane proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.38 |